| Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells D Walter, A Lier, A Geiselhart, FB Thalheimer, S Huntscha, MC Sobotta, ... Nature 520 (7548), 549-552, 2015 | 643 | 2015 |
| Modulating the stem cell niche for tissue regeneration SW Lane, DA Williams, FM Watt Nature biotechnology 32 (8), 795-803, 2014 | 640 | 2014 |
| The leukemic stem cell niche: current concepts and therapeutic opportunities SW Lane, DT Scadden, DG Gilliland Blood, The Journal of the American Society of Hematology 114 (6), 1150-1157, 2009 | 592 | 2009 |
| BET inhibitor resistance emerges from leukaemia stem cells CY Fong, O Gilan, EYN Lam, AF Rubin, S Ftouni, D Tyler, K Stanley, ... Nature 525 (7570), 538-542, 2015 | 519 | 2015 |
| Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia MG Kharas, CJ Lengner, F Al-Shahrour, L Bullinger, B Ball, S Zaidi, ... Nature medicine 16 (8), 903-908, 2010 | 416 | 2010 |
| Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells A Mullally, SW Lane, B Ball, C Megerdichian, R Okabe, F Al-Shahrour, ... Cancer cell 17 (6), 584-596, 2010 | 414 | 2010 |
| AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias SM Sykes, SW Lane, L Bullinger, D Kalaitzidis, R Yusuf, B Saez, F Ferraro, ... Cell 146 (5), 697-708, 2011 | 298 | 2011 |
| Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML FH Heidel, L Bullinger, Z Feng, Z Wang, TA Neff, L Stein, D Kalaitzidis, ... Cell stem cell 10 (4), 412-424, 2012 | 274 | 2012 |
| Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms A Prestipino, AJ Emhardt, K Aumann, D O’Sullivan, SP Gorantla, ... Science translational medicine 10 (429), eaam7729, 2018 | 208 | 2018 |
| mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis D Kalaitzidis, SM Sykes, Z Wang, N Punt, Y Tang, C Ragu, AU Sinha, ... Cell stem cell 11 (3), 429-439, 2012 | 197 | 2012 |
| Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies C Joseph, JM Quach, CR Walkley, SW Lane, CL Celso, LE Purton Cell stem cell 13 (5), 520-533, 2013 | 195 | 2013 |
| Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera A Mullally, C Bruedigam, L Poveromo, FH Heidel, A Purdon, T Vu, ... Blood, The Journal of the American Society of Hematology 121 (18), 3692-3702, 2013 | 182 | 2013 |
| Differential niche and Wnt requirements during acute myeloid leukemia progression SW Lane, YJ Wang, C Lo Celso, C Ragu, L Bullinger, SM Sykes, ... Blood, The Journal of the American Society of Hematology 118 (10), 2849-2856, 2011 | 178 | 2011 |
| Managing haematology and oncology patients during the COVID‐19 pandemic: interim consensus guidance R Weinkove, ZK McQuilten, J Adler, MR Agar, E Blyth, AC Cheng, ... Medical Journal of Australia 212 (10), 481-489, 2020 | 168 | 2020 |
| Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo P Zhang, SK Tey, M Koyama, RD Kuns, SD Olver, KE Lineburg, M Lor, ... The Journal of Immunology 191 (10), 5291-5303, 2013 | 136 | 2013 |
| Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects KH Gartlan, KA Markey, A Varelias, MD Bunting, M Koyama, RD Kuns, ... Blood, The Journal of the American Society of Hematology 126 (13), 1609-1620, 2015 | 121 | 2015 |
| The Apcmin mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS SW Lane, SM Sykes, F Al-Shahrour, S Shterental, M Paktinat, C Lo Celso, ... Blood, The Journal of the American Society of Hematology 115 (17), 3489-3497, 2010 | 121 | 2010 |
| Leukemia stem cells SW Lane, DG Gilliland Seminars in cancer biology 20 (2), 71-76, 2010 | 120 | 2010 |
| Harnessing the immune system in acute myeloid leukaemia R Austin, MJ Smyth, SW Lane Critical reviews in oncology/hematology 103, 62-77, 2016 | 111 | 2016 |
| Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis E Righi, AM Peri, PNA Harris, AM Wailan, M Liborio, SW Lane, ... Journal of Antimicrobial Chemotherapy 72 (3), 668-677, 2017 | 107 | 2017 |
Lars BullingerCharité University Medicine Berlin在 charite.de 的电子邮件经过验证
